Le Lézard
Classified in: Health
Subject: SVY

Local Dermatologist from Tareen Dermatology Has Message to Parents About Checking the Safety of Their Teens' Acne Products


ROSEVILLE, Minn., April 29, 2024 /PRNewswire/ -- In a recent study by Valisure LLC, alarming levels of benzene were found in benzoyl peroxide products commonly used to treat acne in teenagers. Benzene, a known carcinogen, poses serious health risks when exposed to high levels. The Valisure study found the benzene findings to be 12 times the allowed amount by the FDA. Major brands such as Proactiv, Clinique, and Clearasil were all found to have benzene at high levels.

Dr. Mohiba Tareen, a Board-Certified Dermatologist at Tareen Dermatology and leading expert in the field, expressed concerns about the presence of benzene in acne products. "As a dermatologist, my priority is the health and safety of my patients, especially teenagers who are more susceptible to the harmful effects of toxic chemicals like benzene," Dr. Tareen stated.

Benzene is a chemical that has been linked to various health issues, including cancer and respiratory problems. The discovery of benzene in benzoyl peroxide products raises questions about the safety and regulation of acne treatments available in the market.

Dr. Tareen emphasized the importance of parents checking the safety of their teens' acne products. "It is crucial for parents to be vigilant and informed about the ingredients in skincare products, especially those targeting acne. Regularly checking product labels and consulting with dermatologists can help prevent potential health risks," she added.

The findings of this study highlight the urgent need for stricter regulations and thorough testing of skincare products to ensure consumer safety. Dr. Tareen urges parents to prioritize their teens' health by choosing products free from harmful chemicals like benzene.

For more information or to schedule an interview with Dr. Mohiba Tareen, please contact Natalie Borer, Marketing Director at Tareen Dermatology.

Media Contact:
Natalie Borer
Tareen Dermatology
612-559-4791
[email protected]

SOURCE Tareen Dermatology


These press releases may also interest you

at 18:30
BioSyent Inc. ("BioSyent", TSX Venture: RX) released today its financial results for the three months (Q1) ended March 31, 2024. Key highlights include:  (CAD)Q1 2024% Change vs.Q1 2023Trailing Twelve Months(TTM) March 31, 2024% Change vs.TTMMarch...

at 18:00
BioSyent Inc. ("BioSyent", "the Company", TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.045 per common share, payable in Canadian Dollars on June 15, 2024, to shareholders of record at the...

at 18:00
This insightful session is scheduled for May 21, 2024, at 2 pm ET and is co-sponsored by e4health and CBIZ KA Consulting Services. The webinar will feature an in-depth discussion led by Panacea's executive leadership team. They will delve into the...

at 17:45
Talphera, Inc. , ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that management will participate in a fireside chat...

at 17:44
Two bills holding oil drillers accountable for drilling within 3200 feet of a community passed the Assembly Appropriations Committee today by a vote of 11 - 4 and go the Assembly floor....

at 17:30
The global functional food market  size is estimated to grow by USD 127.46 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  7.66%  during the forecast period. ...



News published on and distributed by: